Pharmacodynamic effects of daclizumab in the intrathecal compartmentArticle English OPEN
Komori, Mika; Kosa, Peter; Stein, Jason; Zhao, Vivian; Blake, Andrew; Cherup, Jamie; Sheridan, James; Wu, Tianxia; Bielekova, Bibiana; (2017)
- Publisher: John Wiley and Sons Inc.
- Journal: Annals of Clinical and Translational Neurology,volume 4,issue 7,pages478-490 (eissn: 2328-9503)
- Related identifiers: ,
Subject: Research Article | Research Articles
mesheuropmc: eye diseases
Abstract Objective It was previously demonstrated that daclizumab therapy normalizes cellular cerebrospinal fluid (CSF) abnormalities typical of multiple sclerosis (MS) in the majority of treated patients. However, CSF cells represent only the mobile portion of intrathe... View more